FDA adjusts maximum civil money penalties to account for inflation.
FDA declares personalized medicine “has clearly arrived.”
FDA seeks comment on its determination trans fats are unsafe and should be banned.
Supporters of legislation argue FDA will not cabin its regulatory power on its own.
Court asks government to protect vulnerable people from poorly-run trials.
As mobile health industry grows, regulation looms.